Dexlazo 30 mg (Capsule (Enteric Coated))

Unit Price: ৳ 9.00 (6 x 10: ৳ 540.00)
Strip Price: ৳ 90.00

Medicine Details

Category Details
Generic Dexlansoprazole
Company Desh pharmaceuticals ltd

Indications

  • Healing of Erosive Esophagitis
  • Maintenance of Healed Erosive Esophagitis
  • Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Pharmacology

  • Proton Pump Inhibitor (PPI)
  • Suppression of Gastric Acid Secretion
  • Dual Delayed Release (DDR) Formulation
  • Metabolism in the Liver

Dosage

  • Dexlansoprazole Dosing Recommendations
  • Maintenance of Healed Erosive Esophagitis and Relief of Heartburn
  • Symptomatic Non-Erosive GERD
  • Healing of Erosive Esophagitis
  • 30 mg Once Daily
  • 60 mg Once Daily for Up to 8 Weeks
  • Dexlansoprazole MUPS Dosing Recommendations
  • Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adults and Adolescents
  • 30 mg Tablet Once Daily for 6 Months in Adults
  • 30 mg Tablet Once Daily for 16 Weeks in Patients 12 to 17 Years of Age

Administration

  • Can Be Taken Without Regard to Food
  • Swallowed Whole
  • Sprinkle Intact Granules on One Tablespoon
  • Swallow Immediately
  • Granules Should Not Be Chewed
  • Missed Dose Instructions

Interaction

  • Interactions with Atazanavir, Warfarin, Tacrolimus, Clopidogrel, and Methotrexate

Contraindications

  • Hypersensitivity to Any Component of the Formulation

Side Effects

  • Diarrhea
  • Abdominal Pain
  • Nausea
  • Vomiting
  • Flatulence

Pregnancy & Lactation

  • Pregnancy Category B
  • No Studies in Pregnant Women
  • No Studies in Lactating Mothers

Precautions & Warnings

  • Gastric Malignancy
  • Clostridium difficile Associated Diarrhea
  • Bone Fracture
  • Hypomagnesemia
  • Concomitant Use with Methotrexate

Use in Special Populations

  • Safety and Effectiveness in Children Below 12 Years Not Established
  • No Dose Adjustment Necessary for Elderly Patients
  • No Dose Adjustment Necessary for Patients with Renal Impairment
  • No Dose Adjustment for Patients with Mild Hepatic Impairment
  • Maximum Daily Dose Consideration for Patients with Moderate Hepatic Impairment

Overdose Effects

  • No Reports of Significant Overdose
  • No Death or Severe Adverse Events with Multiple Doses of Dexlansoprazole 120 mg
  • No Death or Severe Adverse Events with Single Dose of Dexlansoprazole 300 mg

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Store Below 30°C Temperature
  • Store in a Dry Place Protected from Light
  • Keep Out of Reach of Children

Related Brands